Llorens-Cortes; Catherine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Llorens-Cortes; Catherine.The latest application filed is for "compounds and compositions comprising the same for treating hypertension or heart failure".

Company Profile

2.5.10

Llorens-Cortes; Catherine - Bures sur Yvette FR
LLORENS-CORTES; Catherine - Paris FR
Llorens-Cortes; Catherine - Burse sur Yvette FR
Llorens-Cortes; Catherine - Burnes sur Yvette FR
Llorens-Cortes; Catherine - Burne sur Yvette FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and compositions comprising the same for treating hypertension or heart failure Grant 11,345,658 - Balavoine , et al. May 31, 2	2022-05-31
Compounds And Compositions Comprising The Same For Treating Hypertension Or Heart Failure App 20220041548 - BALAVOINE; FABRICE ; et al.	2022-02-10
Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same Grant 11,192,907 - Balavoine , et al. December 7, 2	2021-12-07
Novel Aminophosphinic Derivatives As Aminopeptidase A Inhibitors App 20210309677 - BALAVOINE; FABRICE ; et al.	2021-10-07
Aminopeptidase A Inhibitors And Pharmaceutical Compositions Comprising The Same App 20210309678 - BALAVOINE; FABRICE ; et al.	2021-10-07
Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor App 20210206817 - LLORENS-CORTES; Catherine ; et al.	2021-07-08
Combination of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent Grant 10,959,938 - Llorens-Cortes , et al. March 30, 2	2021-03-30
Metabolically Stable Peptide Analogs App 20190328887 - BONNET; Dominique ; et al.	2019-10-31
Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor App 20170355734 - LLORENS-CORTES; Catherine ; et al.	2017-12-14
Combination Of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic Acid) And A Second Antihypertensive Agent App 20150320703 - Llorens-Cortes; Catherine ; et al.	2015-11-12
Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same Grant 7,582,797 - Roques , et al. September 1, 2	2009-09-01
Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same Grant 7,235,687 - Fournie-Zaluski , et al. June 26, 2	2007-06-26
Novel derivatives of 4,4' dithiobis-(3-aminobutane-1-1-sulfonates) and compositions comprising the same App 20060205695 - Roques; Bernard Pierre ; et al.	2006-09-14
Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same App 20060135602 - Fournie-Zaluski; Marie-Claude ; et al.	2006-06-22
Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions App 20020061840 - Roques, Bernard ; et al.	2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.